1. Home
  2. DWSN vs COYA Comparison

DWSN vs COYA Comparison

Compare DWSN & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DWSN

Dawson Geophysical Company

HOLD

Current Price

$5.79

Market Cap

137.3M

Sector

Energy

ML Signal

HOLD

Logo Coya Therapeutics Inc.

COYA

Coya Therapeutics Inc.

HOLD

Current Price

$5.84

Market Cap

124.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DWSN
COYA
Founded
1952
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
137.3M
124.8M
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
DWSN
COYA
Price
$5.79
$5.84
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$15.80
AVG Volume (30 Days)
90.3K
184.7K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
53.85
N/A
EPS
0.25
N/A
Revenue
$145,773,000.00
$7,945,753.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$763.10
P/E Ratio
$23.96
N/A
Revenue Growth
N/A
123.57
52 Week Low
$1.27
$3.71
52 Week High
$6.25
$7.75

Technical Indicators

Market Signals
Indicator
DWSN
COYA
Relative Strength Index (RSI) 68.22 63.67
Support Level $1.75 $5.40
Resistance Level N/A $6.22
Average True Range (ATR) 0.43 0.39
MACD 0.13 0.08
Stochastic Oscillator 80.19 76.87

Price Performance

Historical Comparison
DWSN
COYA

About DWSN Dawson Geophysical Company

Dawson Geophysical Co provides seismic data acquisition services mainly to providers of multi-client data libraries and directly to onshore oil and natural gas exploration and development companies in the continental U.S. and Canada. The demand for seismic services is largely influenced by drilling and completion activity, exploration budgets, and prevailing and anticipated crude oil and natural gas prices. Its data acquisition crews serve companies engaged in the exploration and development of oil and gas on land and in land-to-water transition areas. The business operates through two reportable segments, with U.S. operations generating the majority of revenue and Canada operations contributing additionally.

About COYA Coya Therapeutics Inc.

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.

Share on Social Networks: